Yes, furosemide reliably increases uric acid levels. In one study of heart failure patients taking furosemide, 78% developed hyperuricemia, and the rate climbed with higher doses. This side effect is one of the most common metabolic consequences of loop diuretics and a meaningful concern for anyone with a history of gout or already-elevated uric acid.
How Furosemide Raises Uric Acid
Furosemide works in the kidneys to flush out excess fluid, but it also changes how the kidneys handle uric acid. Normally, your kidneys filter uric acid out of the blood and excrete a portion of it in urine. A key protein called URAT1, located in the lining of the kidney’s filtering tubes, reabsorbs uric acid back into the body. The balance between what gets filtered out and what gets reabsorbed determines your blood uric acid level.
Furosemide disrupts this balance through two main pathways. First, it causes your body to lose fluid, which concentrates uric acid in the blood. Second, and more importantly, it reduces the kidney’s ability to excrete uric acid. A single 20 mg dose of furosemide decreased urinary uric acid excretion by 40% within one to two hours. The fractional clearance of uric acid, a measure of how efficiently the kidneys remove it, dropped by 45% in that same window. Less uric acid leaving the body means more of it building up in the bloodstream.
Interestingly, when tested in isolation on the URAT1 transporter in lab settings, furosemide actually inhibits it by about 40%, which would theoretically help the body excrete more uric acid. But in a living person, the net effect goes the opposite direction. The fluid loss and changes in kidney chemistry that furosemide triggers overpower any direct effect on the transporter, resulting in uric acid retention.
How Fast and How Much It Rises
The effect starts quickly. Plasma uric acid increases by about 6% within 90 minutes of a single dose. With ongoing daily use, the cumulative effect is far more pronounced. Among heart failure patients studied across different dose levels, hyperuricemia rates were striking: 80% in the group taking 20 mg daily, about 82% in the 40 mg group, and 100% in those taking 60 mg or 80 mg daily. Higher doses clearly carry greater risk, though even the lowest dose affected the vast majority of patients.
Hyperuricemia is generally defined as a serum uric acid level above 7 mg/dL in men and above 6 mg/dL in women, though some clinical references use a universal cutoff of 6.8 mg/dL. Readings at or above 8 mg/dL are considered unambiguously elevated.
The Link to Gout
Elevated uric acid is the precursor to gout, the painful joint inflammation caused by uric acid crystals depositing in tissues. Loop diuretics like furosemide are associated with a 2.3-fold increase in the risk of developing gout compared to not taking them. That’s a stronger association than even thiazide diuretics, which carried about a 1.4-fold increase in the same population study of adults with high blood pressure.
An important detail from that research: when the statistical model accounted for serum uric acid levels, the association between loop diuretics and gout disappeared. This confirms that the gout risk isn’t caused by some separate mechanism. Furosemide raises uric acid, and that elevated uric acid is what triggers gout. If you can keep uric acid levels controlled, the diuretic itself doesn’t independently cause joint inflammation.
Complications With Uric Acid-Lowering Drugs
For people who need both furosemide and a medication to lower uric acid, there’s an added wrinkle. Furosemide appears to partially blunt the effectiveness of allopurinol, the most commonly prescribed uric acid-lowering drug. In clinical testing, patients taking both furosemide and allopurinol had significantly higher uric acid levels than matched patients on allopurinol alone, despite taking similar doses. Paradoxically, the active form of allopurinol in the blood was actually higher in the furosemide group, meaning the drug was circulating but not lowering uric acid as expected.
The practical implication is that people on furosemide often need higher doses of allopurinol to reach their target uric acid level. A population-level analysis confirmed this: diuretic use was one of the factors associated with needing a higher allopurinol dose to achieve adequate uric acid reduction.
Kidney Disease Amplifies the Risk
Furosemide is frequently prescribed to people with chronic kidney disease, who already have impaired ability to excrete uric acid. In a large cohort of over 2,300 patients with CKD stages 2 through 5, furosemide use was associated with significantly higher serum uric acid concentrations. This creates a compounding problem: the kidneys are already struggling to clear uric acid, and furosemide further reduces their ability to do so.
For these patients, allopurinol remains the recommended first-line treatment if uric acid levels need to be managed, though starting doses should be lower (50 to 100 mg daily or less, depending on kidney function) with gradual increases. Probenecid, another uric acid-lowering option that works by increasing kidney excretion, is less effective when kidney function is reduced and is not recommended for people with moderate to severe CKD.
Managing Uric Acid While on Furosemide
The 2020 American College of Rheumatology guidelines recommend that gout patients taking a thiazide diuretic switch to a different blood pressure medication when possible. While the guideline specifically names hydrochlorothiazide, the same logic applies to furosemide. Switching isn’t always feasible, particularly for people taking furosemide to manage fluid overload from heart failure or kidney disease, where no true substitute exists.
When furosemide can’t be stopped, monitoring uric acid levels becomes important, especially if you have a history of gout or levels that were already borderline before starting the medication. Allopurinol is the preferred treatment, started at a low dose and increased gradually to bring uric acid below target (typically below 6 mg/dL for gout patients). The key thing to know is that furosemide doesn’t make uric acid-lowering treatment impossible. It just means the dose may need to be higher and the path to target may take longer.